Product Theaters

Advanced Gynecology: Navigating Cervical Cancer Modalities and the Link Between Vaginitis and STI Co-Infections

Neha Deshpande, MD

Join us for a dynamic session examining changes in cervical cancer screening, vaginitis diagnosis, and STI management. This presentation delves into the evolving landscape of cervical cancer screening, addressing key trends such as extended screening intervals and adherence challenges. Gain valuable insights into cervical screening modalities and a comprehensive review of USPSTF guidelines, while assessing the potential role of HPV self-collection. The discussion extends to the complexities of vaginitis diagnosis, focusing on overlapping symptoms, STI co-infections, and the accuracy of NAAT-based testing for precise detection and tailored treatment. Leave equipped with practical strategies for diagnosis and care in women’s health.

Room: Greenpoint/Williamsburg

Learn about a nonhormonal FDA-approved treatment for moderate to severe vasomotor symptoms due to menopause

Lee P. Shulman, MD, Northwestern University Feinberg School of Medicine, Chicago, IL

In this session, we will review an FDA-approved treatment for moderate to severe vasomotor symptoms due to menopause, including indication, mechanism of action, and clinical safety and efficacy.

Room: Salon B/C

A Treatment Option for Your Adult Patients with Postpartum Depression

Sarp Aksel, MD

Sponsored by Sage Therapeutics, Inc. and Biogen Inc.

Room: Navy Yard/Dumbo

A Respiratory Syncytial Virus Prevention Option

Shawana S. Moore, PhD, DNP, APRN, WHNP-BC, PNAP, FAAN Nationally Recognized Board-Certified Women Health Nurse Practitioner, Educator, Researcher Atlanta, GA

Join us for a Pfizer-sponsored informational session to learn more about the following:

• Highlight the burden of disease in infants, including risk of RSV-associated hospitalizations
• Discuss the clinical trial data and real-world evidence for an RSV prevention option
• Learn about the CDC recommendation for an RSV vaccine prevention option

Room: Greenpoint/Williamsburg

Vaginitis: Elevating the Standard of Care

Christine Herde, MD

Tamara Ooms, RN, MS, FNP

Scott M. Rowe, Senior Director of Market Access, Cepheid

Join us for exploration of our new Xpert® Xpress Multiplex Vaginal Panel. A rapid, in-office molecular test for BV, VVC, and TV—enabling same-day diagnosis and treatment—and discuss the broader implications for clinical care and New York State public policy.

Discussion highlights:

• The clinical and patient impact of vaginitis misdiagnosis
• The shift from microscopy to rapid, multiplex molecular testing
• How same-day results can support test-and-treat models
• Considerations for market access and Medicaid policy in New York State

Room: Salon B/C

Natera's New Advancements in Prenatal Genetic Testing: "Beyond Aneuploidy"

Jeffrey T Meltzer, MD MBA, Principal Medical Director, Natera Women's Health

•    Preview of Fetal Focus, a new test that assesses fetal risk for inherited single-gene conditions
•    New vanishing twin capabilities and other unique features from the only SNP-based NIPT
•    How to stay ahead of upcoming genetic testing innovations
•    New resources in patient education, partner testing, billing, and more

Room: Navy Yard/Dumbo

***ACOG recognizes that Product Theaters will be promotional and may concentrate on a specific product or drug. These sessions are not approved for continuing education credits.***